Neutralization, by a polyspecific antivenom, of the coagulopathy induced by the venom of Bothrops asper: assessment by standard coagulation tests and rotational thromboelastometry in a murine model

 

Enregistré dans:
Détails bibliographiques
Auteurs: Camacho Umaña, Erika, Ramírez Vargas, Gabriel, Vargas, Karol, Rucavado Romero, Alexandra, Escalante Muñoz, Teresa, Vargas, Mariángela, Segura Ruiz, Álvaro, Argüello, Ivette, Campos, Marlen, Guerrero, German, Lamela Méndez, Marilla, Gutiérrez, José María
Format: artículo original
Date de publication:2023
Description:Venom-induced consumption coagulopathy and thrombocytopenia are common and potentially severe manifestations of viperid snakebite envenoming since they contribute to local and systemic hemorrhage. Therefore, the assessment of the efficacy of antivenoms to neutralize coagulopathic and thrombocytopenic toxins should be part of the preclinical evaluation of these drugs. To evaluate the efficacy of the polyvalent (Crotalinae) antivenom produced in Costa Rica, in this study we have used a mouse model of coagulopathy and thrombocytopenia induced by the venom of Bothrops asper, based on the bolus intravenous (i.v.) injection of venom. When venom and antivenom were incubated before injection, or when antivenom was administered i.v. immediately after venom injection, venom-induced hemostatic alterations were largely abrogated. We also studied the recovery rate of clotting parameters in conditions where antivenom was administered when mice were coagulopathic. Some parameters recovered more rapidly in antivenom-treated mice than in control envenomed animals, but others showed a spontaneous recovery without antivenom. This is due to a rapid clearance of plasma venom levels in these experimental conditions. This implies that models based on the bolus i.v. injection of venom have limitations for assessing the effect of antivenom in the recovery of clotting alterations once coagulopathy has developed. It is suggested that alternative models should be developed based on a slower systemic absorption of venom. Overall, our findings provide a protocol for the preclinical evaluation of antivenoms and demonstrate that the polyvalent antivenom is effective in neutralizing the toxins of B. asper venom responsible for coagulopathy and thrombocytopenia.
Pays:Kérwá
Institution:Universidad de Costa Rica
Repositorio:Kérwá
Langue:Inglés
OAI Identifier:oai:kerwa.ucr.ac.cr:10669/103189
Accès en ligne:https://www.sciencedirect.com/science/article/pii/S0041010123002878
https://hdl.handle.net/10669/103189
https://doi.org/10.1016/j.toxicon.2023.107301
Mots-clés:Bothrops asper venom
Polyvalent antivenom
Thrombocytopenia
Rotational thromboelastometry
Coagulopathies
Snake venoms